PM Resende
PM Resende publishes mostly in Pathology and Forensic Medicine, Genetics and Oncology, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and CNS Lymphoma Diagnosis and Treatment.
- World rank
- #6,758,699 of 7,710,434 ranked researchers
- Rank in Brazil
- #197,275 of 253,246
- Works
- 27
- Citations
- 0
What does PM Resende research?
PM Resende's work is mostly in Medicine (79%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2179.3%
- Medicine2179.3%
- Everything else620.7%
- 1Pathology and Forensic Medicine24% of their works
- 2Genetics18% of their works
- 3Oncology15% of their works
- 4Hematology10% of their works
- 5Neurology9% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
Which keywords describe PM Resende's research?
The keywords of their largest research topics: Rituximab, Lymphoma, Prognostic Factors, Classification, Molecular Profiling, Chronic Lymphocytic Leukemia, Genomic Aberrations and Primary CNS Lymphoma.
- Imatinib
- Chimeric Antigen Receptor
- CAR T Cells
- Acute Myeloid Leukemia
- AML
- Primary CNS Lymphoma
- Chronic Lymphocytic Leukemia
- Classification
- Lymphoma
- Rituximab
- Prognostic Factors
- Molecular Profiling
- Genomic Aberrations
- Prognostic Scoring System
- Acute Lymphoblastic Leukemia
- BCR-ABL
- Childhood Cancer
- Epstein-Barr Virus
- Kaposi's Sarcoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Rituximab262 topics
- Lymphoma182 topics
- Prognostic Factors173 topics
- Classification151 topic
- Molecular Profiling151 topic
- Chronic Lymphocytic Leukemia111 topic
- Genomic Aberrations111 topic
- Primary CNS Lymphoma51 topic
- Prognostic Scoring System51 topic
- AML31 topic
- Acute Lymphoblastic Leukemia31 topic
- Acute Myeloid Leukemia31 topic
- BCR-ABL31 topic
- CAR T Cells31 topic
- Childhood Cancer31 topic
- Chimeric Antigen Receptor31 topic
- Epstein-Barr Virus31 topic
- Imatinib31 topic
- Kaposi's Sarcoma31 topic
Where does PM Resende work?
PM Resende's main affiliation in the publication record is Hospital Israelita Albert Einstein, Brazil.
How many publications and citations does PM Resende have?
OpenAlex counts 27 works and 0 citations for PM Resende, an h-index of 0, ranking #6,758,699 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about PM Resende. Posts are plain text and can be reported.